Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Pfizer Inc. (PFE) trades at a P/B ratio of 2.0×. Over the past ten years it has ranged from 1.4× (April 2025) to 4.5× (December 2021); the current reading is higher than 26% of that period. That is below the Drug Manufacturers General industry median of 5.0× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.6× (3.96%)
FY2024 1.7× (9.63%)
FY2023 1.9× (37.31%)
FY2022 3.0× (29.81%)
FY2021 4.3× 32.54%
FY2020 3.2× (1.29%)
FY2019 3.3× (14.45%)
FY2018 3.8× 32.42%
FY2017 2.9× (9.61%)
FY2016 3.2× 9.47%

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.6× (9.19%)
Mar 2026 1.8× 8.40%
Dec 2025 1.6× 4.81%
Sep 2025 1.6× 0.50%
42 more quarters

Against its own ten years

Low 1.4× High 4.5×
Ten-year median 2.9×
Current reading's percentile 29

P/B ratio against peers

Company P/B ratio
SNY Sanofi compare 1.2×
PFE Pfizer Inc. 2.0×
GSK GSK PLC Sponsored ADR compare 4.3×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company compare 5.5×
NVS Novartis AG compare 6.8×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PFE